| Identification and importance of brown adipose tissue in adult humans AM Cypess, S Lehman, G Williams, I Tal, D Rodman, AB Goldfine, FC Kuo, ... New England journal of medicine 360 (15), 1509-1517, 2009 | 5062 | 2009 |
| New creatinine-and cystatin C–based equations to estimate GFR without race LA Inker, ND Eneanya, J Coresh, H Tighiouart, D Wang, Y Sang, ... New England Journal of Medicine 385 (19), 1737-1749, 2021 | 1585 | 2021 |
| Activation of human brown adipose tissue by a β3-adrenergic receptor agonist AM Cypess, LS Weiner, C Roberts-Toler, EF Elía, SH Kessler, PA Kahn, ... Cell metabolism 21 (1), 33-38, 2015 | 1090 | 2015 |
| Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice J Liu, A Divoux, J Sun, J Zhang, K Clément, JN Glickman, GK Sukhova, ... Nature medicine 15 (8), 940-945, 2009 | 908 | 2009 |
| Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus MT Malecki, US Jhala, A Antonellis, L Fields, A Doria, T Orban, M Saad, ... Nature genetics 23 (3), 323-328, 1999 | 835 | 1999 |
| A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome C Menzaghi, T Ercolino, R Di Paola, AH Berg, JH Warram, PE Scherer, ... Diabetes 51 (7), 2306-2312, 2002 | 644 | 2002 |
| Residual insulin production and pancreatic β-cell turnover after 50 years of diabetes: Joslin Medalist Study HA Keenan, JK Sun, J Levine, A Doria, LP Aiello, G Eisenbarth, ... Diabetes 59 (11), 2846-2853, 2010 | 619 | 2010 |
| Joslin's Diabetes Mellitus: Edited by C. Ronald Kahn...[et Al.]. EP Joslin, CR Kahn Lippincott Williams & Wilkins, 2005 | 593 | 2005 |
| Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes MA Niewczas, T Gohda, J Skupien, AM Smiles, WH Walker, F Rosetti, ... Journal of the American Society of Nephrology 23 (3), 507-515, 2012 | 499 | 2012 |
| Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease C Menzaghi, V Trischitta, A Doria Diabetes 56 (5), 1198-1209, 2007 | 408 | 2007 |
| The emerging genetic architecture of type 2 diabetes A Doria, ME Patti, CR Kahn Cell metabolism 8 (3), 186-200, 2008 | 403 | 2008 |
| Genetics of non-insulin-dependent (type-II) diabetes mellitus CR Kahn, MD, D Vicent, MD, A Doria, MD, Ph. D Annual review of medicine 47 (1), 509-531, 1996 | 356 | 1996 |
| Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes MG Pezzolesi, GD Poznik, JC Mychaleckyj, AD Paterson, MT Barati, ... Diabetes 58 (6), 1403-1410, 2009 | 341 | 2009 |
| A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes MA Niewczas, ME Pavkov, J Skupien, A Smiles, ZI Md Dom, JM Wilson, ... Nature medicine 25 (5), 805-813, 2019 | 303 | 2019 |
| Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria AS Krolewski, MA Niewczas, J Skupien, T Gohda, A Smiles, JH Eckfeldt, ... Diabetes care 37 (1), 226-234, 2014 | 298 | 2014 |
| Clinical factors associated with resistance to microvascular complications in diabetic patients of extreme disease duration: the 50-year medalist study HA Keenan, T Costacou, JK Sun, A Doria, J Cavellerano, J Coney, ... Diabetes care 30 (8), 1995-1997, 2007 | 290 | 2007 |
| Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist study JK Sun, HA Keenan, JD Cavallerano, BF Asztalos, EJ Schaefer, DR Sell, ... Diabetes care 34 (4), 968-974, 2011 | 286 | 2011 |
| Genetic predisposition to diabetic nephropathy: evidence for a role of the angiotensin I–converting enzyme gene A Doria, JH Warram, AS Krolewski Diabetes 43 (5), 690-695, 1994 | 281 | 1994 |
| High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up LH Ficociello, ET Rosolowsky, MA Niewczas, NJ Maselli, JM Weinberg, ... Diabetes care 33 (6), 1337-1343, 2010 | 273 | 2010 |
| Serum urate lowering with allopurinol and kidney function in type 1 diabetes A Doria, AT Galecki, C Spino, R Pop-Busui, DZ Cherney, I Lingvay, ... New England Journal of Medicine 382 (26), 2493-2503, 2020 | 270 | 2020 |
